Recent Finacing
Recent Raise
TAI Diagnostics develops licensed cell-free DNA assays that quantify donor-specific cfDNA from blood to monitor organ injury after transplant, initially for heart patients, operated through a CLIA/CAP reference lab.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at TAI Diagnostics.
